Ingavirin

英加韦林

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIngavirin
Drug Alias NameImidazolyl EthanamideGlutaryl histamineDicarbaminPentandioic AcidDicarbamine +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHaematopoiesis stimulantsNeutrophils stimulantsApoptosis inhibitors +[4] 
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)NeutropeniaVirus Diseases +[6] 
Global Approved IndicationsNeutropeniaInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2009/01/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesValenta Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesValenta Pharm Jsc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)NeutropeniaInfluenza, Human +[5] 
Inactive IndicationsVirus Diseases

Other Information

ATC CodeJ05AX
Related LinksN/A